Risk stratification of pulmonary embolism

Area of Science:

• Cardiology
• Pulmonary Medicine
• Vascular Disease

Background:

• Pulmonary embolism (PE) is a leading cause of cardiovascular disease mortality.
• PE patient mortality varies significantly, from <0.6% (low-risk) to 19% (high-risk).
• Effective risk stratification guides treatment decisions, balancing urgent reperfusion with conservative management.

Conclusions:

• Risk stratification is essential for tailoring acute pulmonary embolism treatment.
• Accurate risk assessment improves patient outcomes and optimizes resource utilization.
• Differentiating risk levels allows for appropriate escalation or de-escalation of care.